GlassScriptPhysician profile
Kira Robinson
NPI 1407394570
$2,498.71
in general payments reported to CMS, 2019-2025
18 companies · $125 in 2025
The $125 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $132 · 2022: $775 · 2023: $801 · 2024: $666 · 2025: $125.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,592.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,591.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alnylam Pharmaceuticals INC. | $360.81 | 2023-2024 | Givlaari, Amvuttra, Onpattro |
| Gilead Sciences, INC. | $343.41 | 2021-2024 | Veklury |
| Argenx US, INC. | $257.28 | 2022-2023 | Vyvgart |
| Amgen INC. | $248.77 | 2024-2025 | |
| Grifols USA, LLC | $144.75 | 2024 | Prolastin-C Liquid |
| Neurocrine Biosciences, INC. | $137.11 | 2022 | |
| Idorsia Pharmaceuticals US INC | $130.33 | 2022 | |
| Horizon Therapeutics Plc | $124.74 | 2023 | Krystexxa |
| Mylan Specialty L.P. | $117.46 | 2023 | Yupelri |
| Astrazeneca Pharmaceuticals LP | $115.43 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $107.49 | 2022 | |
| Abbvie INC. | $100.82 | 2023 | |
| Sanofi-Aventis U.S. LLC | $93.09 | 2022 | |
| Atricure, INC. | $90.65 | 2023 | |
| Ultragenyx Pharmaceutical INC. | $68.33 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $21.98 | 2023 | |
| Medicure Pharma INC. | $18.41 | 2021 | |
| Glaxosmithkline, LLC. | $17.85 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kira Robinson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.